|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| C12N2310/14 | (2013.01) | ||
| A61K 31/713 | (2006.01) | ||
| C12N2310/315 | (2013.01) | ||
| C07H 21/02 | (2006.01) | ||
| C12N2310/3515 | (2013.01) | ||
| A61K 31/713 | (2013.01) | ||
| A61K 31/7105 | (2013.01) | ||
| C12N 15/1136 | (2013.01) | ||
| C12N2310/351 | (2013.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3656860 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19192281.4 |
| Date of filing the European patent application | 2012-06-20 | |
| (97) | Date of publication of the European application | 2020-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161499620 P | 2011-06-21 | US | |
| 201261638288 P | 2012-04-25 | US |
| (72) |
BETTENCOURT, Brian , US
QUERBES, William , US
FITZGERALD, Kevin , US
FRANK-KAMENETSKY, Maria , US
MILSTEIN, Stuart , US
SHULGA-MORSKAYA, Svetlana , US
|
| (73) |
Alnylam Pharmaceuticals, Inc. ,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |